Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people.

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.

Automated insulin delivery systems improve life expectancy and are highly cost-effective for people with type 1 diabetes.

Skin rash from diabetes medical devices is common, under-recognized, and expected to increase as device use increases.

That silence around Type 1 diabetes is exactly what advocates and educators hope to change. In a move toward inclusivity and awareness, a new Barbie doll has been released, Barbie with Type 1 diabetes ...

Panelists discuss how the rapid adoption of subcutaneous (SubQ) oncology therapies creates challenges around clinical ...

Panelists discuss how switching from intravenous (IV) to subcutaneous (SubQ) therapies requires proactive management of reimbursement, authorizations, and clinical workflows—emphasizing early payer ...

Discover the four key trends and innovations driving infusion therapy for chronic diseases as we head into 2025. Stay informed and up-to-date on the latest advancements in healthcare.

Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says ...

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software, and ...